Abstract:Interdisciplinary research focused on biological membranes has revealed them as signaling and trafficking platforms for processes fundamental to life. Biomembranes harbor receptors, ion channels, lipid domains, lipid signals, and scaffolding complexes, which function to maintain cellular growth, metabolism, and homeostasis. Moreover, abnormalities in lipid metabolism attributed to genetic changes among other causes are often associated with diseases such as cancer, arthritis and diabetes. Thus, there is a need to comprehensively understand molecular events occurring within and on membranes as a means of grasping disease etiology and identifying viable targets for drug development. A rapidly expanding field in the last decade has centered on understanding membrane recruitment of peripheral proteins. This class of proteins reversibly interacts with specific lipids in a spatial and temporal fashion in crucial biological processes. Typically, recruitment of peripheral proteins to the different cellular sites is mediated by one or more modular lipid-binding domains through specific lipid recognition. Structural, computational, and experimental studies of these lipid-binding domains have demonstrated how they specifically recognize their cognate lipids and achieve subcellular localization. However, the mechanisms by which these modular domains and their host proteins are recruited to and interact with various cell membranes often vary drastically due to differences in lipid affinity, specificity, penetration as well as protein-protein and intramolecular interactions. As there is still a paucity of predictive data for peripheral protein function, these enzymes are often rigorously studied to characterize their lipid-dependent properties. This review summarizes recent progress in our understanding of how peripheral proteins are recruited to biomembranes and highlights avenues to exploit in drug development targeted at cellular membranes and/or lipid-binding proteins.

Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids

The Implications for Cells of the Lipid Switches Driven by Protein–Membrane Interactions and the Development of Membrane Lipid Therapy

Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues

Uncovering the Potential of Lipid Drugs: A Focus on Transient Membrane Microdomain-targeted Lipid Therapeutics

Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions

Cellular Membranes and Lipid-Binding Domains As Attractive Targets for Drug Development.

We are what we eat: The role of lipids in metabolic diseases

Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development

Protein lipidation in health and disease: molecular basis, physiological function and pathological implication

Phospholipid Membranes as Chemically and Functionally Tunable Materials

Modulation of Lipid Transport and Adipose Tissue Deposition by Small Lipophilic Compounds

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

Recent advances in novel therapies for lipid disorders

Preparation and Functionality of Lipase-Catalysed Structured Phospholipid – A Review

Sphingolipids and their metabolism in physiology and disease

Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers

Liposome technology for cardiovascular disease treatment and diagnosis

Dyslipidemia: A Narrative Review on Pharmacotherapy

Protein Lipidation in Cell Signaling and Diseases: Function, Regulation, and Therapeutic Opportunities.

Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

Progress of Potential Drugs Targeted in Lipid Metabolism Research.